Skip navigation

Novel organometallic chloroquine derivative inhibits tumor growth

Novel organometallic chloroquine derivative inhibits tumor growth

Lam, Kevin ORCID: 0000-0003-1481-9212 (2018) Novel organometallic chloroquine derivative inhibits tumor growth. Journal of Cellular Biochemistry, 119 (7). pp. 5921-5933. ISSN 0730-2312 (Print), 1097-4644 (Online) (doi:https://doi.org/10.1002/jcb.26787)

[img]
Preview
PDF (Author Accepted Manuscript)
19513 LAM_Novel_Organometallic_Chloroquine_Derivative_Inhibits_Tumor_Growth_2018.pdf - Accepted Version

Download (3MB) | Preview

Abstract

Autophagy has emerged as a mechanism critical to both tumorigenesis and development of resistance to multiple lines of anti-cancer therapy. Therefore, targeting autophagy and alternative cell death pathways has arisen as a viable strategy for refractory tumors. The anti-malarial 4-aminoquinoline compounds chloroquine and hydroxychloroquine are currently being considered for re-purposing as anti- cancer therapies intended to sensitize different tumors by targeting the lysosomal cell death pathway. Here, we describe a novel organometallic chloroquine derivative, cymanquine, that exhibits enhanced bioactivity compared to chloroquine in both normal, and reduced pH tumor microenvironments, thus overcoming a defined limitation of traditional 4-aminoquinolines. In vitro, cymanquine exhibits greater potency than CQ in a diverse panel of human cancer cell lines, including melanoma, in both normal pH and in reduced pH conditions that mimic the tumor microenvironment. Cymanquine treatment results in greater lysosomal accumulation than chloroquine and induces lysosomal dysfunction leading to autophagy blockade. Using a mouse model of vemurafenib-resistant melanoma, cymanquine slowed tumor growth greater than hydroxychloroquine, and when used in combination with vemurafenib, cymanquine partially restored sensitivity to vemurafenib. Overall, we show that cymanquine exhibits superior lysosomal accumulation and autophagy blockade than either chloroquine or hydroxychloroquine in vitro; and in addition to its high level of tolerability in mice, exhibits superior in vivo efficacy in a model of human melanoma.

Item Type: Article
Uncontrolled Keywords: cancer, organometallics, inhibitors, melanoma
Subjects: Q Science > QC Physics
Q Science > QD Chemistry
Faculty / Department / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > Department of Pharmaceutical, Chemical & Environmental Sciences
Last Modified: 26 Mar 2019 01:38
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: GREAT d
Selected for GREAT 2019: None
URI: http://gala.gre.ac.uk/id/eprint/19513

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics